Cargando…
Hematopoietic stem cell transplantation in a severe refractory Crohn’s disease patient with intestinal stoma: a case report
BACKGROUND: Hematopoietic stem cell transplantation (HSCT) can be used in the treatment of patients with refractory Crohn’s disease (CD) when no alternative treatment is available. However, HSCT increases the risk of infections, in particular during the aplasia of mobilization and conditioning. More...
Autores principales: | Ruiz, Milton Artur, Kaiser Junior, Roberto Luiz, de Quadros, Luiz Gustavo, Caseiro, Gustavo Henrique Xavier, Oliveira, Aderson Francisco, Peña-Arciniegas, Tatiana, Piron-Ruiz, Lilian, Kaiser, Fernanda Soubhia Liedtke, Oliveira, Vera Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661443/ https://www.ncbi.nlm.nih.gov/pubmed/29123428 http://dx.doi.org/10.2147/IMCRJ.S139552 |
Ejemplares similares
-
Hematopoietic stem cell transplantation for Crohn’s disease: Gaps, doubts and perspectives
por: Ruiz, Milton Artur, et al.
Publicado: (2018) -
Low toxicity and favorable clinical and quality of life impact after non-myeloablative autologous hematopoietic stem cell transplant in Crohn’s disease
por: Ruiz, Milton Artur, et al.
Publicado: (2017) -
Is it time to use hematopoietic stem cell transplantation for severe and refractory crohn's disease?
por: Ruiz, Milton Artur, et al.
Publicado: (2020) -
Remission of refractory Crohn's disease after autologous hematopoietic stem cell transplantation
por: Ruiz, Milton Artur, et al.
Publicado: (2015) -
Medical, ethical, and legal aspects of hematopoietic stem cell transplantation for Crohn’s disease in Brazil
por: Ruiz, Milton Artur, et al.
Publicado: (2020)